<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Frost KL</submitter><funding>NIEHS NIH HHS</funding><funding>National Institutes of Environmental Health Sciences</funding><funding>NIH</funding><pagination>62-72</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9801707</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>189(1)</volume><pubmed_abstract>Inflammatory liver diseases, including nonalcoholic steatohepatitis (NASH), alcohol-associated liver disease (ALD), hepatitis C virus (HCV), and ALD/HCV, account for nearly 2 million deaths annually. Despite increasing evidence that liver dysfunction impacts renal physiology, there is limited supportive clinical information, due to limited diagnosis of liver disease, complexity in liver disease etiology, and inadequacy of renal function tests. Human kidney biopsies with liver and renal pathology were obtained from patients with nonalcoholic fatty liver disease (NAFLD), NASH, ALD, HCV, and ALD/HCV (n = 5-7). Each liver disease showed renal pathology with at least 50% interstitial nephritis, 50% interstitial fibrosis, and renal dysfunction by estimated glomerular filtration rate (NAFLD 36.7 </pubmed_abstract><journal>Toxicological sciences : an official journal of the Society of Toxicology</journal><pubmed_title>Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination.</pubmed_title><pmcid>PMC9801707</pmcid><funding_grant_id>R01ES028668</funding_grant_id><funding_grant_id>P30ES006694</funding_grant_id><funding_grant_id>P30 ES006694</funding_grant_id><pubmed_authors>Frost KL</pubmed_authors><pubmed_authors>Sinari S</pubmed_authors><pubmed_authors>Cherrington NJ</pubmed_authors><pubmed_authors>Torabzedehkorasani E</pubmed_authors><pubmed_authors>Billheimer DD</pubmed_authors><pubmed_authors>Klein RR</pubmed_authors><pubmed_authors>Schnellmann RG</pubmed_authors><pubmed_authors>Thompson AD</pubmed_authors><pubmed_authors>Jilek JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination.</name><description>Inflammatory liver diseases, including nonalcoholic steatohepatitis (NASH), alcohol-associated liver disease (ALD), hepatitis C virus (HCV), and ALD/HCV, account for nearly 2 million deaths annually. Despite increasing evidence that liver dysfunction impacts renal physiology, there is limited supportive clinical information, due to limited diagnosis of liver disease, complexity in liver disease etiology, and inadequacy of renal function tests. Human kidney biopsies with liver and renal pathology were obtained from patients with nonalcoholic fatty liver disease (NAFLD), NASH, ALD, HCV, and ALD/HCV (n = 5-7). Each liver disease showed renal pathology with at least 50% interstitial nephritis, 50% interstitial fibrosis, and renal dysfunction by estimated glomerular filtration rate (NAFLD 36.7 </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-05T12:09:27.354Z</modification><creation>2025-04-05T12:09:27.354Z</creation></dates><accession>S-EPMC9801707</accession><cross_references><pubmed>35789393</pubmed><doi>10.1093/toxsci/kfac070</doi></cross_references></HashMap>